:

Homeland Security

NIAID Awards $56M in Bio-Defense Contracts

DDN

Wednesday, October 17th, 2007

SHARE:

The National Institute for Allergy and Infectious Diseases (NIAID) has awarded contracts worth $56.1 million to four companies for advanced development of anthrax antitoxins, as well as therapeutics and antibiotics for use against plague and tularemia. The largest award, $20.7 million, went to Nanotherapeutics, Inc., to advance the development of a new approach to formulate an existing antibiotic called Gentamicin so that it can be inhaled for outpatient use. Gentamicin currently can only be administered intravenously in a hospital. The…

Congress

HASC Bill Would Allow Air Force To Buy More Than 267 F-15EXs

The House Armed Services Committee’s (HASC) fiscal 2027 defense authorization bill would allow the Air Force to buy more than 267 F-15EX fighters by Boeing [BA] and would extend the […]

Budget

Defense Bill Tries To Block Foreign Shipbuilding, Adds $1 Billion For Second DDG

The final version of the House Armed Services Committee’s (HASC) fiscal year 2027 defense authorization bill included two amendments pushed by Rep. Jared Golden (D-Maine) that restrict procuring Navy warships […]

Congress

Replacement Munitions May Not Be One-for-One; May Include New Weapons Chemistries, Wittman Says

As the Pentagon looks to refill inventories of weapons used in Iran and elsewhere, replacements may not be one for one but instead mark a new portfolio mix, according to […]

Congress

HASC Approves $1.15 Trillion FY ‘27 NDAA With ‘Right To Repair’ Reform

The House Armed Services Committee (HASC) has approved its $1.15 trillion version of the fiscal year 2027 National Defense Authorization Act (NDAA), with the panel moving to adopt a bipartisan […]